November 10, 2021 11:39 AM EST
Manufacturing

CPhI: Biotech's au­toma­tion boom is on­ly just be­gin­ning amid huge surge in de­mand due to Covid-19

Josh Sullivan

As au­toma­tion creeps its way in­to the biotech and phar­ma man­u­fac­tur­ing world to en­sure con­sis­tent time­lines in the mid­dle of a tu­mul­tuous time for sup­ply …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

Sion­na and Odyssey end JPM week with IPO fil­ings

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times